Trial Summary
What is the purpose of this trial?The primary objective of this research project is to compare the effect of pharmacist interventions versus usual care in the implementation of guideline directed lipid lowering therapies for secondary prevention.
Eligibility Criteria
This trial is for patients with coronary artery disease and high LDL cholesterol levels (>55), who are currently seeing a primary care physician at one of six specific clinics. It excludes women who could become pregnant, those managed by other practices, hospice or long-term care residents, and individuals with end-stage liver disease.Inclusion Criteria
I have been diagnosed with coronary artery disease.
LDL > 55
Primary Care Physician at 1 of 6 identified clinics
Exclusion Criteria
Patients who are no longer an active patient of one of the internal medicine practices
Patients whose cholesterol is managed by another practice
I am a woman who could become pregnant.
+2 more
Participant Groups
The study aims to compare the effectiveness of pharmacist-led interventions in managing cholesterol using guideline-directed therapies versus usual care without this specialized intervention for secondary prevention in very high-risk patients.
2Treatment groups
Experimental Treatment
Active Control
Group I: Pharmacist InterventionExperimental Treatment1 Intervention
Pharmacist review of patient chart and follow up visits to prescribe appropriate therapy for hyperlipidemia.
Group II: ControlActive Control1 Intervention
Chart review only
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
Atrium Health CabarrusConcord, NC
Loading ...
Who Is Running the Clinical Trial?
Wake Forest University Health SciencesLead Sponsor